Clinical trial · Observational
CtDNA After Chemotherapy in Elderly Patients With Acute Leukemia
Monitoring Circulating Tumor DNA After Chemotherapy in Elderly Patients With Acute Leukemia
NCT04157569CI-TRIAL-00043623recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study will monitor CtDNA After Chemotherapy in Elderly Patients With AL
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acute Leukemia | Acute Leukemia | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- cumulative incidence of relapse(CIR)
- timeFrame
- through study completion, an average of 1 year
- description
- cumulative incidence of relapse
Secondary outcomes (1)
- measure
- overall survival (OS)
- timeFrame
- through study completion, an average of 2 years
- description
- overall survival
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 60 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: * Written informed consent * Male * not pregnant female * patients \>=60 years old * Diagnosis of acute leukemia Exclusion Criteria: * Pregnancy * HIV positive * patients \>=100 years old
References
Publications (0)
Data not yet available
No reference posted for this study.